Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 17 de 17
Filtrer
1.
Environ Technol ; 45(12): 2427-2437, 2024 May.
Article de Anglais | MEDLINE | ID: mdl-36705331

RÉSUMÉ

Anammox is one of the most innovative nitrogen removal technologies, while its functional bacteria-anaerobic ammonia-oxidizing bacteria (AAOB) is sensitive to the impurities in the wastewater. In this study, the long-term effects of sulfide at different concentrations (0, 5, 10, 20, 30, 50, 25 mg L-1) on low substrate Anammox process were studied. The results showed that when the sulfide was 25-30 mg L-1, AAOB was well coupled with sulfide-denitrifying bacteria and the total nitrogen removal efficiency (TNRE) reached a maximum of 91.0%. The hydroxylamine oxidoreductase activity and Heme-c reached 1.678 EU g-1 SS and 0.0023 mmol g-1 SS, respectively, with the hzo and nosZ gene concentrations as 2.52 × 108 and 4.45 × 107 copies mL-1. 50 mg L-1 sulfide inhibited the nitrogen removal by AAOB, resulting in the TNRE decreasing to 81.7%. The experimental results provide a reference for the practical application of Anammox in treating sulfur-containing wastewater.


Sujet(s)
Microbiote , Eaux usées , Dénitrification , Azote/analyse , Oxydation anaérobie de l'ammonium , Bioréacteurs/microbiologie , Oxydoréduction , Bactéries/génétique , Sulfures , Eaux d'égout
2.
Fitoterapia ; 151: 104876, 2021 Jun.
Article de Anglais | MEDLINE | ID: mdl-33675885

RÉSUMÉ

Six rocaglaol derivatives were isolated from Dysoxylum gotadhora, and those compounds showed good cytotoxic activity with IC50 values ranging from 10 to 350 ng/mL against five different cancer cells. Obviously, further total synthesis of rocaglaol derivatives for medical chemistry study is of great significance. Then, twenty six rocaglaol derivatives including 25 new compounds were designed, synthesized, and evaluated for their cytotoxic activities against three human cancer cell lines: human colon cancer cells (HCT116), colorectal cancer stem cells (P6C), and human red leukocyte leukemia cells (HEL), using MTT assay. Most of derivatives showed good cytotoxic activities, with the lowest IC50 being 3.2 nM for HEL cells, which was 169 times stronger than that of the positive control (doxorubicin). Further mechanism study indicated that 11k could significantly suppress MAPK pathway in HCT116 cells, which may responsible for induction of apoptosis and cell cycle arrest.


Sujet(s)
Antinéoplasiques d'origine végétale/pharmacologie , Apoptose/effets des médicaments et des substances chimiques , Benzofuranes/pharmacologie , Système de signalisation des MAP kinases/effets des médicaments et des substances chimiques , Meliaceae/composition chimique , Antinéoplasiques d'origine végétale/isolement et purification , Benzofuranes/isolement et purification , Points de contrôle du cycle cellulaire/effets des médicaments et des substances chimiques , Lignée cellulaire tumorale , Chine , Tests de criblage d'agents antitumoraux , Cellules HCT116 , Humains , Structure moléculaire , Composés phytochimiques/isolement et purification , Composés phytochimiques/pharmacologie
3.
Theranostics ; 10(17): 7787-7811, 2020.
Article de Anglais | MEDLINE | ID: mdl-32685020

RÉSUMÉ

Objective: Abnormal proliferation and migration of vascular smooth muscle cells (VSMCs) are essential for vascular remodeling. Natural compounds with diterpene chinone or phenolic acid structure from Salvia miltiorrhiza, an eminent medicinal herb widely used to treat cardiovascular diseases in China, can effectively attenuate vascular remodeling induced by vascular injury. However, it remains unknown whether Salvia miltiorrhiza-derived miRNAs can protect VSMCs from injury by environmental stimuli. Here, we explored the role and underlying mechanisms of Salvia miltiorrhiza-derived Sal-miR-1 and 3 in the regulation of VSMC migration and monocyte adhesion to VSMCs induced by thrombin. Methods: A mouse model for intimal hyperplasia was established by the ligation of carotid artery and the injured carotid arteries were in situ-transfected with Sal-miR-1 and 3 using F-127 pluronic gel. The vascular protective effects of Sal-miR-1 and 3 were assessed via analysis of intimal hyperplasia with pathological morphology. VSMC migration and adhesion were analyzed by the wound healing, transwell membrane assays, and time-lapse imaging experiment. Using loss- and gain-of-function approaches, Sal-miR-1 and 3 regulation of OTUD7B/KLF4/NMHC IIA axis was investigated by using luciferase assay, co-immunoprecipitation, chromatin immunoprecipitation, western blotting, etc. Results:Salvia miltiorrhiza-derived Sal-miR-1 and 3 can enter the mouse body after intragastric administration, and significantly suppress intimal hyperplasia induced by carotid artery ligation. In cultured VSMCs, these two miRNAs inhibit thrombin-induced the migration of VSMCs and monocyte adhesion to VSMCs. Mechanistically, Sal-miR-1 and 3 abrogate OTUD7B upregulation by thrombin via binding to the different sites of the OTUD7B 3'UTR. Most importantly, OTUD7B downregulation by Sal-miR-1 and 3 attenuates KLF4 protein levels via decreasing its deubiquitylation, whereas decreased KLF4 relieves its repression of transcription of NMHC IIA gene and thus increases NMHC IIA expression levels. Further, increased NMHC IIA represses VSMC migration and monocyte adhesion to VSMCs via maintaining the contractile phenotype of VSMCs. Conclusions: Our studies not only found the novel bioactive components from Salvia miltiorrhiza but also clarified the molecular mechanism underlying Sal-miR-1 and 3 inhibition of VSMC migration and monocyte adhesion to VSMCs. These results add important knowledge to the pharmacological actions and bioactive components of Salvia miltiorrhiza. Sal-miR-1 and 3-regulated OTUD7B/KLF4/NMHC IIA axis may represent a therapeutic target for vascular remodeling.


Sujet(s)
microARN/pharmacologie , ARN des plantes/pharmacologie , Salvia miltiorrhiza/génétique , Tunique intime/anatomopathologie , Remodelage vasculaire/effets des médicaments et des substances chimiques , Animaux , Artères carotides/cytologie , Artères carotides/anatomopathologie , Adhérence cellulaire/effets des médicaments et des substances chimiques , Lignée cellulaire , Mouvement cellulaire/effets des médicaments et des substances chimiques , Prolifération cellulaire/effets des médicaments et des substances chimiques , Modèles animaux de maladie humaine , Régulation négative , Endopeptidases/métabolisme , Humains , Hyperplasie/traitement médicamenteux , Hyperplasie/anatomopathologie , Facteur-4 de type Kruppel , Facteurs de transcription Krüppel-like/métabolisme , Mâle , Souris , microARN/usage thérapeutique , Monocytes/effets des médicaments et des substances chimiques , Monocytes/physiologie , Muscles lisses vasculaires/cytologie , Muscles lisses vasculaires/effets des médicaments et des substances chimiques , Myocytes du muscle lisse/effets des médicaments et des substances chimiques , Myocytes du muscle lisse/physiologie , Chaînes lourdes de myosine/métabolisme , ARN des plantes/usage thérapeutique , Transduction du signal/effets des médicaments et des substances chimiques , Tunique intime/effets des médicaments et des substances chimiques
4.
Mol Ther Nucleic Acids ; 21: 492-511, 2020 Sep 04.
Article de Anglais | MEDLINE | ID: mdl-32679544

RÉSUMÉ

Autophagy is associated with the cytoprotection of physiological processes against inflammation and oxidative stress. Salvia miltiorrhiza possesses cardiovascular protective actions and has powerful anti-oxidative and anti-inflammatory effects; however, whether and how Salvia miltiorrhiza-derived microRNAs (miRNAs) protect vascular smooth muscle cells (VSMCs) by inducing autophagy across species are unknown. We first screened and identified Sal-miR-58 from Salvia miltiorrhiza as a natural autophagy inducer. Synthetic Sal-miR-58 suppresses chronic angiotensin II (Ang II) infusion-induced abdominal aortic aneurysm (AAA) formation in mice, as well as induces autophagy in VSMCs and attenuates the inflammatory response elicited by Ang II in vivo and in vitro. Mechanistically, Sal-miR-58 downregulates Krüppel-like factor 3 (KLF3) expression through direct binding to the 3' UTR of KLF3, which in turn relieves KLF3 repression of E3 ubiquitin ligase neural precursor cell-expressed developmentally downregulated 4-like (NEDD4L) expression, whereas NEDD4L upregulation increases the ubiquitination and degradation of the platelet isoform of phosphofructokinase (PFKP), subsequently leading to a decrease in the activation of Akt/mammalian target of rapamycin (mTOR) signaling and facilitating VSMC autophagy induced by Sal-miR-58 in the context of chronic Ang II stimulation and aneurysm formation. Our results provide the first evidence that plant-derived Sal-miR-58 induces autophagy and attenuates inflammation in VSMCs through cross-species modulation of the KLF3/NEDD4L/PFKP regulatory pathway.

5.
Int J Colorectal Dis ; 35(11): 2117-2131, 2020 Nov.
Article de Anglais | MEDLINE | ID: mdl-32720184

RÉSUMÉ

OBJECTIVE: At present, there are many studies on metformin and the risk of colorectal cancer in patients with diabetes, but the conclusions are contradictory. Our aim is to comprehensively collect the published literature and systematically evaluate the relationship between metformin and the risk of colorectal cancer in patients with diabetes. METHODS: We systematically searched the MEDLINE, EMBASE, and CENTRAL databases up to March 2020. We adopted adjusted estimates and their 95% confidence intervals (CI) to calculate summary effect estimates using either a fixed-effects or a random-effects model. RESULTS: A total of 17 articles were included in this study, with a total of 1,092,074 patients with diabetes. Meta-analysis of observational studies showed that metformin treatment could significantly reduce the incidence of colorectal cancer in diabetic patients (adjusted RR = 0.884, 95%CI = 0.829-0.943), and there was heterogeneity between studies (p = 0.013, I2 = 47.9%). Subgroup analysis showed that metformin treatment was significantly associated with a significantly reduced risk of colorectal cancer in diabetics in America and Europe (adjusted RR = 0.852, 95%CI = 0.786-0.924; adjusted RR = 0.900, 95%CI = 0.845-0.958). Patients with diabetes treated with metformin had a significantly lower risk of colorectal cancer compared with patients who had never been treated with metformin or sulfonamide monotherapy (adjusted RR = 0.863, 95%CI = 0.776-0.960; adjusted RR = 0.911, 95%CI = 0.882-0.941). CONCLUSIONS: Metformin therapy is associated with a significantly reduced risk of colorectal disease in patients with diabetes, and it is necessary to conduct larger, more standardized clinical studies to verify this conclusion.


Sujet(s)
Tumeurs colorectales , Diabète de type 2 , Metformine , Tumeurs colorectales/épidémiologie , Diabète de type 2/complications , Diabète de type 2/traitement médicamenteux , Diabète de type 2/épidémiologie , Europe , Humains , Hypoglycémiants/usage thérapeutique , Metformine/usage thérapeutique
6.
Eur J Pharmacol ; 880: 173140, 2020 Aug 05.
Article de Anglais | MEDLINE | ID: mdl-32387370

RÉSUMÉ

The inflammation and proliferation of vascular smooth muscle cells (VSMCs) are the basic pathological feature of proliferative vascular diseases. Tanshinone ⅡA (Tan ⅡA), which is the most abundant fat-soluble element extracted from Salvia miltiorrhiza, has potent protective effects on the cardiovascular system. However, the underlying mechanism is still not fully understood. Here, we show that Tan ⅡA significantly inhibits neointimal formation and decreases VSMC inflammation by upregulating the expression of KLF4 and inhibiting the activation of NFκB signaling. Using a microRNA array analysis, we found that miR-712-5p expression is significantly upregulated in tumor necrosis factor alpha (TNF-α)-treated VSMCs. Loss- and gain-of-function experiments revealed that transfection of miR-712-5p mimic promotes, whereas depletion of miR-712-5p suppresses TNF-α-induced VSMC inflammation, leading to amelioration of intimal hyperplasia induced by carotid artery ligation. Moreover, depletion of miR-712-5p by its antagomir largely abrogates TNF-α-induced VSMC proliferation. Our findings suggest that miR-712-5p mediates the stimulatory effect of TNF-α on VSMC inflammation, and that Tan ⅡA inhibits VSMC inflammation and proliferation in vivo and in vitro by suppression of miR-712-5p expression. Targeting miR-712-5p may be a novel therapeutic strategy to prevent proliferative vascular diseases.


Sujet(s)
Abiétanes/pharmacologie , Anti-inflammatoires/pharmacologie , microARN , Myocytes du muscle lisse/effets des médicaments et des substances chimiques , Animaux , Artères carotides/anatomopathologie , Lignée cellulaire , Prolifération cellulaire/effets des médicaments et des substances chimiques , Cytokines/génétique , Cytokines/métabolisme , Régulation négative/effets des médicaments et des substances chimiques , Hyperplasie/génétique , Hyperplasie/métabolisme , Hyperplasie/anatomopathologie , Facteur-4 de type Kruppel , Facteurs de transcription Krüppel-like/génétique , Mâle , Souris de lignée C57BL , Muscles lisses vasculaires/cytologie , Myocytes du muscle lisse/métabolisme , Néointima/génétique , Néointima/métabolisme , Néointima/anatomopathologie
7.
Bioresour Technol ; 302: 122829, 2020 Apr.
Article de Anglais | MEDLINE | ID: mdl-32028147

RÉSUMÉ

The existence of CO2 in biogas will affect its practicality, so the methanation of CO2 is of great significance. Carrier materials play a key role in bioconversion of CO2 to methane during biogas upgrading. Herein, different materials were used to evaluate the bioconversion process of CO2 to methane, which consisted of black ceramsite (BC) and biochars prepared from corn straw and digestate. The results showed that after adding the carrier materials, the methane production rate increased by more than 20%, and the corn straw biochar (CSB) group even increased by more than 70%. This may be attributed to the large specific surface area and more functional groups in corn straw biochar which was suitable for the immobilization of hydrogenotrophic methanogens (HMs). Therefore, corn straw biochar is a good carrier material for the accelerated bioconversion of CO2 to methane.


Sujet(s)
Bioréacteurs , Euryarchaeota , Biocarburants , Charbon de bois , Méthane
8.
Sci Rep ; 8(1): 2535, 2018 02 07.
Article de Anglais | MEDLINE | ID: mdl-29416061

RÉSUMÉ

The aim of this study was to investigate the prognostic value of the lymphocyte-to-monocyte ratio (LMR) in patients undergoing hepatectomy and to compare it to established biomarkers including the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR). Medical records were retrospectively analyzed for 652 HCC patients undergoing hepatectomy at the Affiliated Tumor Hospital of Guangxi Medical University and the First People's Hospital of Changde between April 2004 to April 2012. The correlation between the LMR and clinical variables were analyzed in Kaplan-Meier log-rank survival analysis and then multivariate Cox regression models trying to find relation with disease-free survival (DFS) and overall survival (OS). The area under the ROC curve (AUC) of the LMR(AUC:0.627) for predicting long-term survival was greater than that of the NLR(AUC:0.600) and the PLR(AUC:0.520).Multivariate analysis showed LMR to be an independent risk factor for OS (P = 0.002), and the NLR and PLR were not independently significant. Subgroup analysis also showed that LMR was significantly associated with poor DFS and OS in patients positive for HBsAg or with cirrhosis (both P < 0.001).Elevated preoperative LMR is an independently associated with poor OS and DFS in HCC patients following curative resection and appears to be superior to NLR and PLR.


Sujet(s)
Carcinome hépatocellulaire/diagnostic , Carcinome hépatocellulaire/mortalité , Tumeurs du foie/diagnostic , Tumeurs du foie/mortalité , Lymphocytes/immunologie , Monocytes/immunologie , Adulte , Marqueurs biologiques tumoraux/sang , Hémogramme , Carcinome hépatocellulaire/immunologie , Carcinome hépatocellulaire/chirurgie , Chine , Survie sans rechute , Femelle , Hépatectomie , Humains , Estimation de Kaplan-Meier , Tumeurs du foie/chirurgie , Mâle , Adulte d'âge moyen , Période préopératoire , Pronostic , Modèles des risques proportionnels , Études rétrospectives
9.
Mol Med Rep ; 16(4): 4823-4828, 2017 Oct.
Article de Anglais | MEDLINE | ID: mdl-28849128

RÉSUMÉ

The super-saturation of serum with monosodium urate due to hyperuricemia is the core metabolic disorder of rheumatoid arthritis. When the serum urate concentration is ≥7 mg/dl, this results in the crystallization of monosodium urate in serum at body temperature (37˚C/98.6˚F). Colchicine (COL) is considered to be a first­line medication for acute arthritis when NSAIDs are contraindicated. COL causes severe side effects, including diarrhea, nausea, cramping, abdominal pain and vomiting, in humans. Experimental studies have additionally demonstrated the presence of mutagenic and reproductive effects in humans. In the present study, molecular docking simulation techniqueswere used to design COL­derived bioisosteric inhibitors, with the aim of designing an alternative treatment that exhibitedpotent anti­arthritic activity and was free from the side effects associated with COL.


Sujet(s)
Colchicine/analogues et dérivés , Colchicine/composition chimique , Conception de médicament , Simulation de docking moléculaire , Simulation de dynamique moléculaire , Modulateurs de la polymérisation de la tubuline/composition chimique , Tubuline/composition chimique , Polyarthrite rhumatoïde/traitement médicamenteux , Colchicine/pharmacologie , Humains , Ligands , Structure moléculaire , Modulateurs de la polymérisation de la tubuline/pharmacologie
10.
Tumour Biol ; 39(6): 1010428317707375, 2017 Jun.
Article de Anglais | MEDLINE | ID: mdl-28639906

RÉSUMÉ

The Platelet to lymphocyte ratio (PLR) has been reported to predict prognosis of patients with hepatocellular carcinoma (HCC). This study examined the prognostic potential of stratified PLR for HCC patients undergoing curative liver resection. Medical records were retrospectively analyzed for 778 HCC patients undergoing curative liver resection at the Affiliated Tumor Hospital of Guangxi Medical University and the First People's Hospital of Changde between April 2010 and October 2013. Patients were stratified based on quintile analysis of their preoperative PLR, and patients in different quintiles were analyzed for overall survival (OS) and disease-free survival (DFS) using Kaplan-Meier analysis. Independent predictors of death or recurrence were explored using multivariable Cox proportional hazard regression. Higher PLR quintiles were significantly associated with poorer overall survival (p < 0.001). Multivariate analysis showed PLR to be an independent risk factor for OS (p = 0.003). Patients in PLR quintile 5 had lower overall survival than in quintile 1 (hazard ratio (HR) = 2.780, 95% confidence interval (CI): 1.769-4.367, p < 0.001). Although patients in PLR quintile 5 had significantly lower disease-free survival (DFS) than in quintile 1 (HR = 1.534, 95% CI: 1.112-2.117, p = 0.009), this association was not significant after multivariable adjustment (p = 0.220). Subgroup analysis also showed that PLR quintiles were significantly associated with poor OS in patients positive for HBsAg or with cirrhosis (both p < 0.001). Similar results were obtained when PLR was analyzed as a dichotomous variable with cut-off values of 110 and 115. Elevated preoperative PLR may be independently associated with poor OS and DFS in HCC patients following curative resection.


Sujet(s)
Marqueurs biologiques tumoraux/sang , Plaquettes , Carcinome hépatocellulaire/sang , Tumeurs du foie/sang , Lymphocytes , Adulte , Sujet âgé , Carcinome hépatocellulaire/anatomopathologie , Survie sans rechute , Femelle , Humains , Estimation de Kaplan-Meier , Tumeurs du foie/anatomopathologie , Mâle , Adulte d'âge moyen , Récidive tumorale locale/sang , Récidive tumorale locale/anatomopathologie , Numération des plaquettes , Pronostic
11.
Biomed Environ Sci ; 30(5): 351-362, 2017 May.
Article de Anglais | MEDLINE | ID: mdl-28549491

RÉSUMÉ

OBJECTIVE: To investigate chondrocyte apoptosis and the expression of biochemical markers associated with apoptosis in Kashin-Beck disease (KBD) and in an established T-2 toxin- and selenium (Se) deficiency-induced rat model. METHODS: Cartilages were collected from the hand phalanges of five patients with KBD and five healthy children. Sprague-Dawley rats were administered a selenium-deficient diet for 4 weeks prior to T-2 toxin exposure. The apoptotic chondrocytes were observed by terminal deoxynucleotidyl transferase dUTP nick end labeling staining. Caspase-3, p53, Bcl-2, and Bax proteins in the cartilages were visualized by immunohistochemistry, their protein levels were determined by Western blotting, and mRNA levels were determined by real-time reverse transcription polymerase chain reaction. RESULTS: Increased chondrocyte apoptosis was observed in the cartilages of children with KBD. Increased apoptotic and caspase-3-stained cells were observed in the cartilages of rats fed with normal and Se-deficient diets plus T-2 toxin exposure compared to those in rats fed with normal and Se-deficient diets. Caspase-3, p53, and Bax proteins and mRNA levels were higher, whereas Bcl-2 levels were lower in rats fed with normal or Se-deficiency diets supplemented with T-2 toxin than the corresponding levels in rats fed with normal diet. CONCLUSION: T-2 toxin under a selenium-deficient nutritional status induces chondrocyte death, which emphasizes the role of chondrocyte apoptosis in cartilage damage and progression of KBD.


Sujet(s)
Apoptose/effets des médicaments et des substances chimiques , Cartilage articulaire/physiopathologie , Chondrocytes/physiologie , Maladie de Kashin-Beck/physiopathologie , Sélénium/déficit , Toxine T-2/pharmacologie , Adolescent , Animaux , Marqueurs biologiques , Enfant , Femelle , Humains , Maladie de Kashin-Beck/étiologie , Mâle , Matrilines/génétique , Matrilines/métabolisme , Modèles animaux , Répartition aléatoire , Rats , Rat Sprague-Dawley
12.
Tumour Biol ; 39(3): 1010428317695944, 2017 Mar.
Article de Anglais | MEDLINE | ID: mdl-28351330

RÉSUMÉ

The aspartate aminotransferase-to-platelet ratio index has been reported to predict prognosis of patients with hepatocellular carcinoma. This study examined the prognostic potential of stratified aspartate aminotransferase-to-platelet ratio index for hepatocellular carcinoma patients undergoing curative liver resection. A total of 661 hepatocellular carcinoma patients were retrieved and the associations between aspartate aminotransferase-to-platelet ratio index and clinicopathological variables and survivals (overall survival and disease-free survival) were analyzed. Higher aspartate aminotransferase-to-platelet ratio index quartiles were significantly associated with poorer overall survival (p = 0.002) and disease-free survival (p = 0.001). Multivariate analysis showed aspartate aminotransferase-to-platelet ratio index to be an independent risk factor for overall survival (p = 0.018) and disease-free survival (p = 0.01). Patients in the highest aspartate aminotransferase-to-platelet ratio index quartile were at 44% greater risk of death than patients in the first quartile (hazard ratio = 1.445, 95% confidence interval = 1.081 - 1.931, p = 0.013), as well as 49% greater risk of recurrence (hazard ratio = 1.49, 95% confidence interval = 1.112-1.998, p = 0.008). Subgroup analysis also showed aspartate aminotransferase-to-platelet ratio index to be an independent predictor of poor overall survival and disease-free survival in patients positive for hepatitis B surface antigen or with cirrhosis (both p < 0.05). Similar results were obtained when aspartate aminotransferase-to-platelet ratio index was analyzed as a dichotomous variable with cutoff values of 0.25 and 0.62. Elevated preoperative aspartate aminotransferase-to-platelet ratio index may be independently associated with poor overall survival and disease-free survival in hepatocellular carcinoma patients following curative resection.


Sujet(s)
Aspartate aminotransferases/sang , Plaquettes/métabolisme , Carcinome hépatocellulaire/sang , Tumeurs du foie/sang , Adulte , Sujet âgé , Carcinome hépatocellulaire/anatomopathologie , Carcinome hépatocellulaire/chirurgie , Survie sans rechute , Femelle , Humains , Tumeurs du foie/anatomopathologie , Tumeurs du foie/chirurgie , Mâle , Adulte d'âge moyen , Période préopératoire , Pronostic , Résultat thérapeutique
13.
World J Gastroenterol ; 22(39): 8798-8805, 2016 Oct 21.
Article de Anglais | MEDLINE | ID: mdl-27818595

RÉSUMÉ

AIM: To determine whether cyclooxygenase-2 (COX-2) and prostaglandin E1 receptor (EP1) contribute to disease and whether they help predict prognosis. METHODS: We retrospectively reviewed the records of 116 patients with hepatocellular carcinoma (HCC) who underwent surgery between 2008 and 2011 at our hospital. Expression of COX-2 and EP1 receptor was examined by immunohistochemistry of formalin-fixed, paraffin-embedded tissues using polyclonal antibodies. Possible associations between immunohistochemical scores and survival were determined. RESULTS: Factors associated with poor overall survival (OS) were alpha-fetoprotein > 400 ng/mL, tumor size ≥ 5 cm, and high EP1 receptor expression, but not high COX-2 expression. Disease-free survival was not significantly different between patients with low or high levels of COX-2 or EP1. COX-2 immunoreactivity was significantly higher in well-differentiated HCC tissues (Edmondson grade I-II) than in poorly differentiated tissues (Edmondson grade III-IV) (P = 0.003). EP1 receptor immunoreactivity was significantly higher in poorly differentiated tissue than in well-differentiated tissue (P = 0.001). CONCLUSION: COX-2 expression appears to be linked to early HCC events (initiation), while EP1 receptor expression may participate in tumor progression and predict survival.


Sujet(s)
Carcinome hépatocellulaire/enzymologie , Cyclooxygenase 2/biosynthèse , Cyclooxygenase 2/métabolisme , Régulation de l'expression des gènes tumoraux , Tumeurs du foie/enzymologie , Sous-type EP1 des récepteurs des prostaglandines E/métabolisme , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Carcinome hépatocellulaire/imagerie diagnostique , Carcinome hépatocellulaire/mortalité , Évolution de la maladie , Survie sans rechute , Femelle , Humains , Immunohistochimie , Tumeurs du foie/imagerie diagnostique , Tumeurs du foie/mortalité , Mâle , Adulte d'âge moyen , Pronostic , Études rétrospectives , Résultat thérapeutique
14.
World J Gastroenterol ; 22(21): 5088-95, 2016 Jun 07.
Article de Anglais | MEDLINE | ID: mdl-27275101

RÉSUMÉ

AIM: To investigate whether an elevated preoperative neutrophil-to-lymphocyte ratio (NLR) can predict poor survival in patients with hepatocellular carcinoma (HCC). METHODS: We retrospectively reviewed 526 patients with HCC who underwent surgery between 2004 and 2011. RESULTS: Preoperative NLR ≥ 2.81 was an independent predictor of poor disease-free survival (DFS, P < 0.001) and overall survival (OS, P = 0.044). Compared with patients who showed a preoperative NLR < 2.81 and postoperative increase, patients who showed preoperative NLR ≥ 2.81 and postoperative decrease had worse survival (DFS, P < 0.001; OS, P < 0.001). Among patients with preoperative NLR ≥ 2.81, survival was significantly higher among those showing a postoperative decrease in NLR than among those showing an increase (DFS, P < 0.001; OS, P < 0.001). When elevated, alpha-fetoprotein (AFP) provided no prognostic information, and so preoperative NLR ≥ 2.81 may be a good complementary indicator of poor OS whenever AFP levels are low or high. CONCLUSION: Preoperative NLR ≥ 2.81 may be an indicator of poor DFS and OS in patients with HCC undergoing surgery. Preoperative NLR ≥ 2.81 may be a good complementary indicator of poor OS when elevated AFP levels provide no prognostic information.


Sujet(s)
Carcinome hépatocellulaire/chirurgie , Hépatectomie , Tumeurs du foie/chirurgie , Lymphocytes , Granulocytes neutrophiles , Adulte , Carcinome hépatocellulaire/sang , Carcinome hépatocellulaire/mortalité , Carcinome hépatocellulaire/anatomopathologie , Loi du khi-deux , Chine , Survie sans rechute , Femelle , Hépatectomie/effets indésirables , Hépatectomie/mortalité , Humains , Estimation de Kaplan-Meier , Tumeurs du foie/sang , Tumeurs du foie/mortalité , Tumeurs du foie/anatomopathologie , Numération des lymphocytes , Mâle , Adulte d'âge moyen , Valeur prédictive des tests , Score de propension , Modèles des risques proportionnels , Études rétrospectives , Facteurs de risque , Facteurs temps , Résultat thérapeutique , Alphafoetoprotéines/analyse
15.
Oncol Lett ; 11(5): 3145-3151, 2016 May.
Article de Anglais | MEDLINE | ID: mdl-27123080

RÉSUMÉ

Substantial evidence implicates that low-abundance cancer stem cells (CSCs) are responsible for tumor metastasis and recurrence in hepatocellular carcinoma (HCC). Side population (SP) cells possess typical CSCs-like features, and are frequently considered as a special subpopulation in which CSCs are enriched and in studies may be considered as a substitute for CSCs. The aim of the present study was to examine the abundance of SP cells in human HCC cell lines with different metastatic potentials and compare their CSC-like, tumorigenic and invasive properties with those of the main population (MP) cells. An experimental system is described for identifying SP cells and analyzing their CSC-like properties. The relative abundance of SP cells correlated directly with the metastatic potential of the HCC cell line: HCCLM3, 16.3±2.2%; MHCC97-H, 8.4±0.7%; MHCC97-L, 4.7±0.5%; and Huh7, 1.0±0.3% (P<0.05). SP cells isolated from HCCLM3 cultures showed significantly higher proliferation rates and clonogenicity than the corresponding MP cells, in addition to higher migration and invasive abilities in vitro and greater tumorigenicity in mice. Expression levels of all CSC-associated genes tested, except EpCAM and Oct4, were significantly higher in SP cells. The findings revealed that the proportion of SP cells correlates with metastatic potential, and SP cells demonstrated the characteristics expected of CSCs, implicating them in HCC metastasis. Further studies on the identification and characterization of SP cells using clinical HCC specimens will contribute to the understanding of how SP cells are involved in these disease processes.

16.
Medicine (Baltimore) ; 94(44): e1806, 2015 Nov.
Article de Anglais | MEDLINE | ID: mdl-26554780

RÉSUMÉ

Cancer stem cells (CSCs) are thought to be responsible for tumor relapse and metastasis due to their abilities to self-renew, differentiate, and give rise to new tumors. Cyclooxygenase-2 (COX-2) is highly expressed in several kinds of CSCs, and it helps promote stem cell renewal, proliferation, and radioresistance. Whether and how COX-2 contributes to CSC migration and invasion is unclear. In this study, COX-2 was overexpressed in the CSC-like side population (SP) of the human hepatocellular carcinoma (HCC) cell line HCCLM3. COX-2 overexpression significantly enhanced migration and invasion of SP cells, while reducing expression of metastasis-related proteins PDCD4 and PTEN. Treating SP cells with the selective COX-2 inhibitor celecoxib down-regulated COX-2 and caused a dose-dependent reduction in cell migration and invasion, which was associated with up-regulation of PDCD4 and PTEN. These results suggest that COX-2 exerts pro-metastatic effects on SP cells, and that these effects are mediated at least partly through regulation of PDCD4 and PTEN expression. These results further suggest that celecoxib may be a promising anti-metastatic agent to reduce migration and invasion by hepatic CSCs.


Sujet(s)
Carcinome hépatocellulaire/génétique , Cyclooxygenase 2/génétique , ADN tumoral/génétique , Régulation de l'expression des gènes tumoraux , Tumeurs du foie/génétique , Cellules souches tumorales/anatomopathologie , Technique de Western , Carcinome hépatocellulaire/métabolisme , Carcinome hépatocellulaire/anatomopathologie , Lignée cellulaire tumorale , Mouvement cellulaire , Cyclooxygenase 2/biosynthèse , Cytométrie en flux , Humains , Tumeurs du foie/métabolisme , Tumeurs du foie/anatomopathologie , Invasion tumorale , Réaction de polymérisation en chaine en temps réel
17.
World J Gastroenterol ; 21(15): 4627-34, 2015 Apr 21.
Article de Anglais | MEDLINE | ID: mdl-25914472

RÉSUMÉ

AIM: To compare survival and recurrence in hepatocellular carcinoma (HCC) patients who did or did not receive adjuvant transarterial chemoembolization (TACE). METHODS: A consecutive sample of 229 patients who underwent curative resection between March 2007 and March 2010 in our hospital was included. Of these 229 patients, 91 (39.7%) underwent curative resection followed by adjuvant TACE and 138 (60.3%) underwent curative resection alone. In order to minimize confounds due to baseline differences between the two patient groups, comparisons were conducted between propensity score-matched patients. Survival data and recurrence rates were compared using the Kaplan-Meier method. Independent predictors of overall survival and recurrence were identified using Cox proportional hazard regression. RESULTS: Among 61 pairs of propensity score-matched patients, the 1-, 2-, and 3-year overall survival rates were 95.1%, 86.7%, and 76.4% in the TACE group and 86.9%, 78.5%, and 73.2% in the control group, respectively. At the same time, the TACE and control groups also showed similar recurrence rates at 1 year (13.4% vs 24.8%), 2 years (30.6% vs 32.1%), and 3 years (40.1% vs 34.0%). Multivariate Cox regression identified serum alpha-fetoprotein level ≥ 400 ng/mL and tumor size > 5 cm as independent risk factors of mortality (P < 0.05). CONCLUSION: As postoperative adjuvant TACE does not improve overall survival or reduce recurrence in HCC patients, further study is needed to clarify its clinical benefit.


Sujet(s)
Carcinome hépatocellulaire/thérapie , Chimioembolisation thérapeutique , Hépatectomie , Tumeurs du foie/thérapie , Adulte , Carcinome hépatocellulaire/sang , Carcinome hépatocellulaire/mortalité , Carcinome hépatocellulaire/anatomopathologie , Chimioembolisation thérapeutique/effets indésirables , Chimioembolisation thérapeutique/mortalité , Traitement médicamenteux adjuvant , Loi du khi-deux , Chine , Survie sans rechute , Femelle , Hépatectomie/effets indésirables , Hépatectomie/mortalité , Humains , Estimation de Kaplan-Meier , Tumeurs du foie/sang , Tumeurs du foie/mortalité , Tumeurs du foie/anatomopathologie , Mâle , Adulte d'âge moyen , Analyse multifactorielle , Récidive tumorale locale , Score de propension , Modèles des risques proportionnels , Études rétrospectives , Facteurs de risque , Facteurs temps , Résultat thérapeutique , Charge tumorale , Alphafoetoprotéines/analyse
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE